CoQ10 for Health & Longevity - Quick Reference Sheet
evipedia.aidev
← Back

CoQ10 for Health & Longevity

Created on 08/24/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4.5 – Audit

Coenzyme Q10 is a fat-soluble helper molecule the body makes for cellular energy. Production falls with age and cholesterol-lowering drugs. Evidence is strongest in heart failure, with further support for blood pressure, migraine, fatigue, blood fats, fertility-treatment pregnancy, and mood. Parkinson motor decline was not slowed. Lifespan extension from CoQ10 alone is unproven. Stomach upset is the usual side effect. (Full Review)

Protocol

Standard longevity range
100–200 mg daily
Oral CoQ10 with a fat-containing meal
Time of day
Morning or midday with food
Avoids insomnia reports tied to evening dosing
Half-life and splitting
Split amounts above 100–200 mg
~33-hour half-life; once-daily can sustain plasma levels
Time to effect
Heart-failure events
2 years
Not a 16-week functional change
Systolic blood pressure
8–12 weeks
When they occur; lipid shifts appear in the same window
Migraine and fatigue
8–12 weeks
Migraine often 12 weeks before a full effect

Benefits

Contraindications
  • Known soy or peanut allergy with oil-based soy-lecithin softgels
  • Warfarin without timely INR checks after a dose change
  • Pregnancy or breastfeeding outside a supervised trial
  • Active cytotoxic chemotherapy or radiation unless the oncology team has reviewed
    •
Key Interactions
  • Warfarin (Coumadin, Jantoven)
  • Antihypertensives (lisinopril, amlodipine, hydrochlorothiazide)
  • Diabetes drugs (metformin, insulin, sulfonylureas such as glipizide)
  • Statins (atorvastatin, rosuvastatin, simvastatin)
  • Other pressure or fatigue supplements (hibiscus, beetroot nitrate, magnesium, PQQ / pyrroloquinoline quinone)
  • Theophylline
  • Over-the-counter blood thinners and anti-inflammatory pain relievers (aspirin, ibuprofen, naproxen)
  • Grapefruit juice
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal symptoms; Sleep disruption; Warfarin effect; Additive blood-pressure lowering; Headache, dizziness, and rash
    •
  • Speculative: Interference with chemotherapy or radiation; Theophylline interaction
    •

Monitoring

Marker Target Why
Plasma CoQ10 ≥2.0 µg/mL on therapy Confirms absorption and a supplemented steady state
Seated systolic/diastolic blood pressure <120/80 mmHg functional Tracks the most replicated cardiometabolic surrogate
LDL-C Individual target (often <70–100 mg/dL in high-risk prevention) Small CoQ10 lipid shifts are not statin-scale change
HbA1c (if diabetic or prediabetic) Individual target (often <5.7% metabolic; <6.5% diagnostic) Tracks glucose status; CoQ10's glycemic effect is not established
CK (if on a statin) Stay within the lab reference interval or the person's own baseline Separates subjective myalgia from enzyme-defined injury
INR (if on warfarin) Stay in the person's prescribed therapeutic band Catches a possible CoQ10–warfarin shift

Cadence: Baseline before the first dose; 8–12 weeks; then every 6–12 months. INR recheck 3–7 days after starting or stopping if on warfarin

Qualitative Assessment

  • Sleep quality and evening restlessness
  • Daytime energy and training recovery
  • Migraine-day count (if applicable)
  • Statin-associated muscle comfort (if applicable)
  • Gastrointestinal tolerance after dose changes
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.